REBECCA LALUMANDIER: Open Payments
NPI 1710574215 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$322 in 14 payments from 7 companies in 2025. Trend: 2023 $177 · 2024 $214 · 2025 $322
Food & beverage: $232Education: $90
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 1 | $90 |
| Janssen Biotech, Inc. | 4 | $74 |
| Lilly USA, LLC | 3 | $52 |
| ABBVIE INC. | 2 | $45 |
| Incyte Corporation | 2 | $33 |
| Amgen Inc. | 1 | $14 |
| Cipher Pharmaceuticals US LLC | 1 | $14 |
Products named: DUPIXENT, TREMFYA, TALTZ, SKYRIZI, OPZELURA, OTEZLA, Natroba.
Industry payments across KY — which companies pay providers there.
